7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

C42H56BBrN8O4 — CID 161493060

IUPAC7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESC.C.CC1(C)OB(c2cnn(C3CCCCO3)c2)OC1(C)C.Cc1ccc2ncc(-c3cnn(C4CCCCO4)c3)cc2n1.Cc1ccc2ncc(Br)cc2n1
InChIInChI=1S/C17H18N4O.C14H23BN2O3.C9H7BrN2.2CH4/c1-12-5-6-15-16(20-12)8-13(9-18-15)14-10-19-21(11-14)17-4-2-3-7-22-17;1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12;1-6-2-3-8-9(12-6)4-7(10)5-11-8;;/h5-6,8-11,17H,2-4,7H2,1H3;9-10,12H,5-8H2,1-4H3;2-5H,1H3;2*1H4
InChIKeyWFVOWEMVCKAKIR-UHFFFAOYSA-N
MW827.68 g/mol
LogP9.36
Rot. Bonds4

About 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (PubChem CID 161493060) has the molecular formula C42H56BBrN8O4 and a molecular weight of 827.68 g/mol. Its IUPAC name is 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.

Molecular Properties

Compound Name7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
PubChem CID161493060
Molecular FormulaC42H56BBrN8O4
Molecular Weight827.68 g/mol
Exact Mass826.37
IUPAC Name7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESC.C.CC1(C)OB(c2cnn(C3CCCCO3)c2)OC1(C)C.Cc1ccc2ncc(-c3cnn(C4CCCCO4)c3)cc2n1.Cc1ccc2ncc(Br)cc2n1
InChIInChI=1S/C17H18N4O.C14H23BN2O3.C9H7BrN2.2CH4/c1-12-5-6-15-16(20-12)8-13(9-18-15)14-10-19-21(11-14)17-4-2-3-7-22-17;1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12;1-6-2-3-8-9(12-6)4-7(10)5-11-8;;/h5-6,8-11,17H,2-4,7H2,1H3;9-10,12H,5-8H2,1-4H3;2-5H,1H3;2*1H4
InChIKeyWFVOWEMVCKAKIR-UHFFFAOYSA-N
XLogP9.36
TPSA124.12 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds4
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500827.68
LogP ≤ 59.36
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The IUPAC name of 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (CID 161493060) is 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.
What is the SMILES notation for 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The canonical SMILES for 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is C.C.CC1(C)OB(c2cnn(C3CCCCO3)c2)OC1(C)C.Cc1ccc2ncc(-c3cnn(C4CCCCO4)c3)cc2n1.Cc1ccc2ncc(Br)cc2n1.
What is the InChIKey of 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The InChIKey is WFVOWEMVCKAKIR-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H18N4O.C14H23BN2O3.C9H7BrN2.2CH4/c1-12-5-6-15-16(20-12)8-13(9-18-15)14-10-19-21(11-14)17-4-2-3-7-22-17;1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12;1-6-2-3-8-9(12-6)4-7(10)5-11-8;;/h5-6,8-11,17H,2-4,7H2,1H3;9-10,12H,5-8H2,1-4H3;2-5H,1H3;2*1H4.
What are the key properties of 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole has a molecular weight of 827.68 g/mol, XLogP of 9.36, 4 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 7-bromo-2-methyl-1,5-naphthyridine;methane;2-methyl-7-[1-(oxan-2-yl)pyrazol-4-yl]-1,5-naphthyridine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is sourced from PubChem (CID 161493060), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).